Literature DB >> 22714597

Therapeutic pneumoperitoneum in a patient with pulmonary tuberculosis and persistent fever.

M Antoniou1, D Chloros, D Spyratos, P Giouleka, L Sichletidis.   

Abstract

Artificial pneumoperitoneum represents a therapeutic technique first applied in the treatment of pulmonary tuberculosis (TB) in prechemotherapy antimycobacterial era. A 25-year-old patient presented with pulmonary TB diagnosed during the 8th month of her pregnancy. She was febrile and in severe clinical condition. An antituberculous regimen of four primary drugs was initiated immediately after the caesarean section. There was no clinical improvement after 3 months despite full drug sensitivity of Mycobacterium tuberculosis isolates. An artificial pneumoperitoneum was applied along with the drug treatment for 6 months. Soon the patient became afebrile, her body weight increased and sputum smears gave negative results. The combination of the old technique of therapeutic pneumoperitoneum along with the current antituberculosis treatment proved to be effective in this advanced case of pulmonary TB initially unresponsive to drug therapy alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22714597      PMCID: PMC3062282          DOI: 10.1136/bcr.05.2010.2968

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Collapse therapy (medical) in pulmonary tuberculosis.

Authors:  F H SCADDING
Journal:  Postgrad Med J       Date:  1954-06       Impact factor: 2.401

2.  Pneumoperitoneum in the treatment of pulmonary tuberculosis; a critical review.

Authors:  F J MENENDEZ
Journal:  Dis Chest       Date:  1953-09

3.  Pneumoperitoneum in the treatment of pulmonary tuberculosis; results in 710 cases from 1937 to 1946.

Authors:  R S MITCHELL; J S HIATT
Journal:  Am Rev Tuberc       Date:  1947-04

4.  Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis.

Authors:  M D Iseman; L Madsen; M Goble; M Pomerantz
Journal:  Am Rev Respir Dis       Date:  1990-03

5.  Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis.

Authors:  A T Nitta; M D Iseman; J D Newell; L A Madsen; M Goble
Journal:  Clin Infect Dis       Date:  1993-02       Impact factor: 9.079

6.  [Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis].

Authors:  T R Bagdasarian; I A Vasil'eva; A T Sigaev; V I Chukanov
Journal:  Probl Tuberk Bolezn Legk       Date:  2006
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.